Major Depressive Disorder
Showing NaN - NaN of 62
MDD Trial in United States (OPC-34712, Placebo, ADT)
MDD Trial in United States (ADT, OPC-34712)
Completed
- Major Depressive Disorder
-
Arcadia, California
- +31 more
Oct 6, 2015
MDD Trial in United States (OPC-34712, Placebo, ADT)
MDD Trial in United States (tasimelteon, )
Completed
- Major Depressive Disorder
- tasimelteon
- placebo
-
Garden Grove, California
- +39 more
Jun 1, 2015
MDD Trial in Portland (Interactive voice messaging or Interactive voice messaging + psycho ed materials)
Completed
- Major Depressive Disorder
- Interactive voice messaging or Interactive voice messaging + psycho ed materials
-
Portland, OregonKaiser Permanente Center for Health Research
Mar 12, 2015
MDD Trial in Worldwide (Desvenlafaxine succinate sustained release 50 mg, Desvenlafaxine succinate sustained release 25 mg,
Completed
- Major Depressive Disorder
- Desvenlafaxine succinate sustained release 50 mg
- +2 more
-
Beverly Hills, California
- +88 more
Nov 6, 2014
MDD Trial in United States (Vilazodone, Placebo to citalopram, Placebo to vilazodone)
MDD Trial in United States (Placebo, Escitalopram, JNJ-18038683)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Little Rock, Arkansas
- +25 more
Aug 1, 2014
MDD, Depression Trial in India, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Tuscaloosa, Alabama
- +50 more
Mar 14, 2014
MDD, MDD, Depression Trial in Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- +2 more
- TC-5214
- Placebo
-
Birmingham, Alabama
- +93 more
Mar 14, 2014
MDD, Depression Trial in India, Puerto Rico, United States (TC-5214, Placebo)
Completed
- Major Depressive Disorder
- Depression
- TC-5214
- Placebo
-
Birmingham, Alabama
- +98 more
Mar 14, 2014
MDD Trial in Portland (Cognitive Behavioral Therapy (CBT), Active control)
Completed
- Major Depressive Disorder
- Cognitive Behavioral Therapy (CBT)
- Active control
-
Portland, OregonKaiser Permanente Center for Health Research
Jan 30, 2014
MDD Trial in United States (desvenlafaxine succinate sustained-release 50 mg/day, desvenlafaxine succinate sustained-release 100
Completed
- Major Depressive Disorder
- desvenlafaxine succinate sustained-release 50 mg/day
- +2 more
-
Phoenix, Arizona
- +60 more
Dec 17, 2013
MDD Trial in United States (Aripiprazole+ ADT, Placebo+ ADT)
Completed
- Major Depressive Disorder
- Aripiprazole+ ADT
- Placebo+ ADT
-
Birmingham, Alabama
- +33 more
Nov 7, 2013
MDD Trial in United States (Antidepressant + Placebo, Antidepressant + Aripiprazole)
Completed
- Major Depressive Disorder
- Antidepressant + Placebo
- Antidepressant + Aripiprazole
-
Beverly Hills, California
- +27 more
Nov 22, 2013
MDD Trial in United States (Antidepressant + Placebo, Antidepressant + Aripiprazole)
Completed
- Major Depressive Disorder
- Antidepressant + Placebo
- Antidepressant + Aripiprazole
-
Garden Grove, California
- +19 more
Nov 22, 2013
MDD Trial in United States (Antidepressant + Aripiprazole)
Completed
- Major Depressive Disorder
- Antidepressant + Aripiprazole
-
Mesa, Arizona
- +57 more
Nov 7, 2013
MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Birmingham, Alabama
- +50 more
Aug 22, 2013
MDD Trial in United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Phoenix, Arizona
- +37 more
Aug 22, 2013
MDD Trial in United States (Levomilnacipran ER, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Scottsdale, Arizona
- +24 more
Aug 22, 2013
MDD Trial in Worldwide (TC-5214, Duloxetine, Placebo)
Terminated
- Major Depressive Disorder
- TC-5214
- +2 more
-
Beverly Hills, California
- +66 more
Nov 14, 2012
MDD Trial in United States (AZD2066, Placebo, Duloxetine)
MDD Trial in United States (F2695 SR)
Completed
- Major Depressive Disorder
- F2695 SR
-
Dothan, Alabama
- +67 more
Aug 15, 2012